Tumor necrosis factor-like weak inducer of apoptosis regulates particle-induced inflammatory osteolysis via the p38 mitogen-activated protein kinase signaling pathway

Molecular Medicine Reports

Volumn 12, Issue 1, 2015, Pages 1499-1505

  Zhang, Zhiqiang ^a,b   Fang, Yongchao ^b   Wang, Qiang ^b   Sun, Yu ^b   Xiong, Chuanzhi ^b   Cao, Li ^b   Wang, Beiyue ^a   Bao, Nirong ^a   Zhao, Jianning ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b NORTHERN JIANGSU PEOPLE S HOSPITAL   (China)

Author keywords

P38 mitogen activated protein kinase; Periprosthetic osteolysis; Phosphorylated p38 mitogen activated protein kinase; Prosthetic loosening; Tumor necrosis factor like weak inducer of apoptosis; Wear particles

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; TITANIUM; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR LIKE WEAK INDUCER OF APOPTOSIS PROTEIN; UNCLASSIFIED DRUG; CCL2 PROTEIN, MOUSE; TNFSF12 PROTEIN, MOUSE;

ADOLESCENT; ADULT; AGED; ANIMAL CELL; ARTICLE; CELL INFILTRATION; CHILD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; JOINT PROSTHESIS; MACROPHAGE; MALE; MONOCYTE; MOUSE; NONHUMAN; OSTEOARTHRITIS; OSTEOLYSIS; PROSTHESIS LOOSENING; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SYNOVIOCYTE; SYNOVIUM; UPREGULATION; WESTERN BLOTTING; ADVERSE EFFECTS; ANIMAL; APOPTOSIS; BIOSYNTHESIS; CHEMICALLY INDUCED; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HIP ARTHROPLASTY; INFLAMMATION; METABOLISM; PATHOLOGY;

ANIMALS; APOPTOSIS; ARTHROPLASTY, REPLACEMENT, HIP; CHEMOKINE CCL2; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTERLEUKIN-6; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; MICE; OSTEOLYSIS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; TITANIUM; TUMOR NECROSIS FACTORS;

EID: 84926678653     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.3529     Document Type: Article

References (31)

1. Moro T, Kyomoto M, Ishihara K, et al Grafting of poly(2-methacryloyloxyethyl phosphorylcholine) on polyethylene liner in artificial hip joints reduces production of wear particles. J Mech Behav Biomed Mater 31 100-106, 2014.
2. Fujii J, Yasunaga Y, Yamasaki A and Ochi M Wear debris stimulates bone-resorbing factor expression in the fibroblasts and osteoblasts. Hip Int, 2011.
3. Antonios JK, Yao Z, Li C, Rao AJ and Goodman SB Macrophage polarization in response to wear particles in vitro. Cell Mol Immunol 10 471-482, 2013.
4. Nich C, Takakubo Y, Pajarinen J, et al Macrophages-Key cells in the response to wear debris from joint replacements. J Biomed Mater Res A 101 3033-3045, 2013.
5. Shimamura M, Nakagami H, Osako MK, et al OPG/RANKL/RANK axis is a critical inflammatory signaling system in ischemic brain in mice. Proc Natl Acad Sci USA 111 8191-8196, 2014.
6. Ma B, Zhang Q, Wu D, et al Strontium fructose 1,6-diphosphate prevents bone loss in a rat model of postmenopausal osteoporosis via the OPG/RANKL/RANK pathway. Acta Pharmacol Sin 33 479-489, 2012.
7. Zhang X, Paun A, Claudio E, Wang H and Siebenlist U The tumor promoter and NF-κB modulator Bcl-3 regulates splenic B cell development. J Immunol 191 5984-5992, 2013.
8. Dwyer BJ, Olynyk JK, Ramm GA and Tirnitz-Parker JE TWEAK and LTβ signaling during chronic liver disease. Front Immunol 5 39, 2014.
9. Martin P, Mora I, Cortes A, et al Relevant role of cGMP-dependent protein kinase (PKG) in the progression of fibrosis induced by TNF-like weak inducer of apoptosis (TWEAK). Am J Physiol Renal Physiol 307 F75-F85, 2014.
10. Winkles JA The TWEAK-Fn14 cytokine-receptor axis discovery, biology and therapeutic targeting. Nat Rev Drug Discov 7 411-425, 2008.
11. Yang Q, Xu Y, Feng G, et al p38 MAPK signal pathway involved in anti-inflammatory effect of Chaihu-Shugan-San and Shen-ling-bai-zhu-San on hepatocyte in non-alcoholic steatohepatitis rats. Afr J Tradit Complement Altern Med 11 213-221, 2014.
12. Moreira V, Lomonte B, Vinolo MA, Curi R, Gutierrez JM and Teixeira C An Asp49 phospholipase A2 from snake venom induces cyclooxygenase-2 expression and prostaglandin E2 production via activation of NF-kappa B, p38MAPK, and PKC in Macrophages. Mediators Inflamm 2014 2014.
13. Wang X and Liu Y Regulation of innate immune response by MAP kinase phosphatase-1. Cell Signal 19 1372-1382, 2007.
14. Zhi-Chun L, Qiao-Ling Z, Zhi-Qin L, Xiao-Zhao L, Xiao-xia Z and Rong T Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) mediates p38 mitogen-activated protein kinase activation and signal transduction in peripheral blood mononuclear cells from patients with lupus nephritis. Inflammation 35 935-943, 2012.
15. Li H, Mittal OK, Paul PK, et al Tumor necrosis factor-related weak inducer of apoptosis augments matrix metallopro-teinase 9 (MMP-9) production in skeletal muscle through the activation of nuclear factor-kappaB-inducing kinase and p38 mitogen-activated protein kinase A potential role of MMP-9 in myopathy. J Biol Chem 284 4439-4450, 2009.
16. Wisniacki N, Amaravadi L, Galluppi GR, et al Safety, tolerability, pharmacokinetics, and pharmacodynamics of anti-TWEAK monoclonal antibody in patients with rheumatoid arthritis. Clin Ther 35 1137-1149, 2013.
17. Xue K, Qi L, Zhou G and Liu K A two-step method of constructing mature cartilage using bone marrow-derived mesenchymal stem cells. Cells Tissues Organs 197 484-495, 2013.
18. Schultz DC, Bazel S, Wright LM, et al Western blotting and enzymatic activity analysis of cathepsin D in breast tissue and sera of patients with breast cancer and benign breast disease and of normal controls. Cancer Res 54 48-54, 1994.
19. Xiao W, Chen X and He M Inhibition of the Jagged/Notch pathway inhibits retinoblastoma cell proliferation via suppressing the PI3K/Akt, Src, p38MAPK and Wnt/βcatenin signaling pathways. Mol Med Rep 10 453-458, 2014.
20. Purdue PE, Koulouvaris P, Potter HG, Nestor BJ and Sculco TP The cellular and molecular biology of periprosthetic osteolysis. Clin Orthop Relat Res 454 251-261, 2007.
21. Gallo J, Goodman SB, Konttinen YT and Raska M Particle disease biologic mechanisms of periprosthetic osteolysis in total hip arthroplasty. Innate Immun 19 213-224, 2013.
22. Ingham E and Fisher J The role of macrophages in osteolysis of total joint replacement. Biomaterials 26 1271-1286, 2005.
23. Pajarinen J, Kouri VP, Jamsen E, Li TF, Mandelin J and Konttinen YT The response of macrophages to titanium particles is determined by macrophage polarization. Acta Biomater 9 9229-9240, 2013.
24. Goodman SB, Ma T, Spanogle J, et al Effects of a p38 MAP kinase inhibitor on bone ingrowth and tissue differentiation in rabbit chambers. J Biomed Mater Res A 81 310-316, 2007.
25. Tsirigotis M, Baldwin RM, Tang MY, Lorimer IA and Gray DA Activation of p38MAPK contributes to expanded polyglutamine-induced cytotoxicity. PloS One 3 e2130, 2008.
26. Desplat-Jégo S, Feuillet L, Creidy R, et al TWEAK is expressed at the cell surface of monocytes during multiple sclerosis. J Leukoc Biol 85 132-135, 2009.
27. Mao X, Pan X, Peng X, Cheng T and Zhang X Inhibition of titanium particle-induced inflammation by the proteasome inhibitor bortezomib in murine macrophage-like RAW264.7 cells. Inflammation 35 1411-1418, 2012.
28. Goodman SB, Gibon E, Pajarinen J, et al Novel biological strategies for treatment of wear particle-induced periprosthetic osteolysis of orthopaedic implants for joint replacement. J R Soc Interface 11 20130962, 2014.
29. van Kuijk AW, Wijbrandts CA, Vinkenoog M, Zheng TS, Reedquist KA and Tak PP TWEAK and its receptor Fn14 in the synovium of patients with rheumatoid arthritis compared to psoriatic arthritis and its response to tumour necrosis factor blockade. Ann Rheum Dis 69 301-304, 2010.
30. Perper SJ, Browning B, Burkly LC, et al TWEAK is a novel arthritogenic mediator. J Immunol 177 2610-2620, 2006.
31. Neale SD and Athanasou NA Cytokine receptor profile of arthroplasty macrophages, foreign body giant cells and mature osteoclasts. Acta Orthop Scand 70 452-458, 1999.